Status:
COMPLETED
PCT for Speech, Language, and Cognitive Intervention in Stroke Patients
Lead Sponsor:
The Learning Corp
Conditions:
Aphasia, Acquired
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Given the evolving uses of technology in rehabilitation, the investigators aimed to measure the change in aphasia severity using PCT App, a digital therapeutic adapted from Constant Therapy (CT), a dy...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Have diagnosis of stroke involving a hemorrhage or ischemic event, resulting in speech, language, and/or cognitive deficits
- Have time post-stroke of at least 4 months prior to enrollment
- Have been discharged from rehabilitation hospital
- Are adults (aged 18 years or older) at the time of consent
- Exhibit clinically confirmed speech, language, and/or cognitive deficits based on medical records
- Are fluent English speakers
- Have confirmed aphasia using the WAB-R Aphasia Quotient (score of 90 or lower; 93.8 is cutoff for normal scores)
- Have a presence of a family member or caregiver who is willing and able to provide assistance during the duration of study period
- Exclusion Criteria:
- Have comorbid neurological conditions that could impair study participation in the opinion of the investigator, such as dementia or Parkinson's disease
- Currently require inpatient care or acute care
- Are currently undergoing related one-on-one individual therapy at a hospital, rehabilitation facility, university, or at home
- Exhibit severe apraxia of speech or severe dysarthria of speech, as verified by a clinician and confirmed by the WAB-R (and the Screen for Dysarthria and Apraxia of Speech if necessary), and/or medical records
- Have comorbid psychiatric conditions that could impair study participation in the opinion of the investigator, including such as schizophrenia or major depressive disorder, as indicated by medical records
- Have uncorrected hearing or vision loss
Exclusion
Key Trial Info
Start Date :
March 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04488029
Start Date
March 18 2019
End Date
February 20 2020
Last Update
July 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Learning Corp
Newton, Massachusetts, United States, 02458